TO THE EDITOR Chronic myelogenous leukemia (CML) is usually characterized by the presence of the Philadelphia (Ph) translocation, t(9;22)(q34;q11). BCR-ABL fusion in Ph translocation is well known to be critical in the pathogenesis. The interest in treating this disease is now focused on a novel oncoprotein p210
BCR-ABL as a target molecule. On the other hand, a minority of patients with CML have cytogenetically normal leukemic cells. A subgroup in Ph-negative patients showed a rearrangement of the major BCR. 1 A previous report, analyzing patients with Ph-negative CML showed M-BCR rearrangement in 11 out of 23 patients. 2 Insertion of a small segment of chromosome 9 (9q34) into chromosome 22q11 was suggested to form M-BCR in Ph-negative CML. 3, 4 A unique complex translocation: t(9;12;15)(q34;q12;q21) in a CML patient has been reported to mask the Ph chromosome. 5 Fluorescence in situ hybridization (FISH) has become useful to confirm cytogenetic diagnosis in Ph-positive and -negative CML. 6 Seong et al, 7 using hypermetaphase FISH, reported that two out of six Ph-negative CML patients had ABL insertions into the BCR gene on chromosome 22. In Ph-negative CML, retranslocation between chromosomes 9q+ and 22q− was postulated to result in normal-looking chromosomes 9 and 22. 1 We here report a patient with t(20;22)(q13;q11) accompanying BCR-ABL fusion on chromosome 22 which resulted in a normal-looking cytogenetic study by the Giemsa-banding method.
A /l) and myeloid hyperplasia (myeloyd/erythroid ratio, 12.9) with 2.4% myeloblasts, 1.2% promyelocytes, 13.2% eosinophils, 1.6% basophils and 6.4% erythroblasts. All of the hematologic results were compatible with typical CML. Chromosomal findings of bone marrow cells seemed to be 46,XX in 20 cells (Figure 1a ). Based on these data, Ph-negative CML was diagnosed. Detection of the major BCR-ABL mRNA of bone marrow cells from this patient by RT-PCR analysis was performed as previously described, 8 using a primer ABL1 (5′-GGC CCA TGG TAC CAG GAG TG-3′) as a reverse transcription primer, followed by the amplification of cDNA with a first primer pair ABL1 and BCR1 (5′-GCT TCT CCC TGA CAT CCG TG-3′) for 35 cycles and a second primer pair ABL2 (5′-GTT TCT CCA GAC TGT TGA CTG-3′) and BCR2 (5′-GGA GCT GCA GAT GCT GAC CAA C-3′) for 35 cycles, respectively. RT-PCR analysis detected a 446 bp major BCR-ABL transcript, corresponding to b3a2 fusion (Figure 1c ). FISH analysis of BCR-ABL fusion revealed 60.8% positive as compared to 1.9% positive in a normal control. Dual-color FISH analysis demonstrated a BCR-ABL fusion signal on one chromosome 22, a normal green ABL signal and a normal red BCR signal on one chromosome 9 and the other chromosome 22, respectively (Figure 1d ). Karyotyping by SKY 9 showed t(20;22) without detectable segmental translocation of the 9q34 region (Figure 1b) . She was given hydroxyurea for about 2 months, and then was given interferon-alpha after being found positive for major BCR-ABL by RT-PCR analysis.
Ph-negative and BCR-positive CML patients are now easily analyzed using molecular techniques. The finding of BCR-ABL molecular rearrangements indicates undetected Ph translocation in Ph-negative patients. Cytogenetic study in this patient failed to demonstrate Ph translocation. RT-PCR analysis indicated that this patient had BCR-ABL rearrangement. This finding was confirmed by dual-color FISH analysis demonstrating a BCR-ABL fusion signal on one chromosome 22. Meanwhile, karyotyping by SKY analysis demonstrated t(20;22) without abnormality in chromosome 9. These results indicate that only a small segment of chromosome 9 including ABL is located on chromosome 22. Inazawa et al 1 speculated that retranslocation between chromosome 9 and 22 might result in Ph-negative CML. Other reports suggested insertion of a small segment of chromosome 9 into chromosome 22 to form M-BCR in Ph-negative CML. 3, 4 Moreover, masked Ph chromosomes in the literature usually have a 9q+ anomaly that inspires further examination of the translocated part on 9q34. However, the current case showed neither 9q+ nor 22q− anomaly using standard G-and Q-bandings.
A single cytogenetic event seems to be more plausible than a two- A BCR-ABL fusion signal was found on one chromosome 22 (arrow), while a normal green ABL signal and a normal red BCR signal were found on one chromosome 9 and the other chromosome 22, respectively. step translocation mechanism. Complex translocation could also create BCR-ABL fusion masking the Ph translocation. 5 In the present patient, the most likely explanation is the insertion of a small segment of chromosome 9, including ABL into chromosome 22 during translocation between 20 and 22, the breakpoint of which was close to BCR. This single-step mechanism seems to be more likely than a dual step mechanism of insertion of ABL into chromosome 22 before t(20;22). Another interesting point is the normal looking chromosome 9 in this patient. No deletion or addition of 9q34 region was seen despite the translocation of ABL. In the reported cases of insertion of ABL gene into 22q11, no case has appeared to determine the exact karyotypic changes of the distal part of 22q11-ter using SKY. Thus, more detailed cytogenetic study will contribute to understanding the mechanism of the insertion of the ABL gene at the BCR.
Large numbers of Ph-negative CML patients are BCR-ABL-positive at the molecular level. These patients seem to be heterogeneous. Recently, karyotyping by SKY analysis has become widely available. This case presents one example of masked Ph CML. In the near future,
it may be possible to analyze large study groups of Ph-negative CML like this case.
